FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $37,655,000 | -4.6% | 456,699 | +5.2% | 0.03% | -14.7% |
| Q4 2020 | $39,471,000 | +645.9% | 434,086 | +227.9% | 0.03% | +466.7% |
| Q3 2020 | $5,292,000 | +1927.6% | 132,399 | +1642.1% | 0.01% | – |
| Q2 2020 | $261,000 | +52.6% | 7,600 | -1.3% | 0.00% | – |
| Q1 2020 | $171,000 | -75.5% | 7,700 | -77.6% | 0.00% | -100.0% |
| Q2 2019 | $699,000 | -7.4% | 34,439 | -19.8% | 0.00% | 0.0% |
| Q1 2019 | $755,000 | +17.1% | 42,943 | -14.5% | 0.00% | 0.0% |
| Q4 2018 | $645,000 | -23.7% | 50,233 | -3.2% | 0.00% | 0.0% |
| Q3 2018 | $845,000 | – | 51,899 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |